JOURNAL OF BUON, vol.14, no.3, pp.429-433, 2009 (SCI-Expanded)
Article / Article
JOURNAL OF BUON
Science Citation Index Expanded (SCI-EXPANDED), Scopus
cisplatin, epirubicin, gastric cancer, metastatic, UFT, PHASE-II, 1ST-LINE CHEMOTHERAPY, COLORECTAL-CANCER, ORAL UFT, CISPLATIN, EPIRUBICIN, FLUOROURACIL, CARCINOMA, URACIL, TRIAL
Dokuz Eylül University Affiliated:
Purpose: Gastric cancer is the 4th most commonly diagnosed cancer and the 2nd leading cause of cancer death worldwide. In this study assessed were the efficacy and toxicity of the combination of epirubicin, cisplatin and UFT in patients with metastatic gastric cancer (MGC).